Filter
253
Text search:
inactivated
vaccines
Featured
Recommendations
24
New Publications
73
Language
Document type
No document type
116
Guidelines
66
Studies & Reports
28
Fact sheets
17
Manuals
13
Strategic & Response Plan
6
Situation Updates
5
Training Material
1
Resource Platforms
1
Countries / Regions
Global
10
Pakistan
8
India
7
Sierra Leone
6
Nigeria
6
Philippines
6
South Africa
6
Afghanistan
5
Tanzania
5
Latin America and the Carribbean
5
Syria
4
Kenya
4
Ukraine
4
Chile
4
Ethiopia
3
Uganda
3
Nepal
3
Germany
3
Africa
3
Liberia
2
Congo, Democratic Republic of
2
Namibia
2
Myanmar / Burma
2
East and Southern Africa
2
Middle East and North Africa
2
South–East Asia Region
2
Venezuela
2
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Zambia
1
Turkey
1
Egypt
1
China
1
Rwanda
1
Bangladesh
1
Malawi
1
Papua New Guinea
1
Argentina
1
Peru
1
Brazil
1
Colombia
1
Ecuador
1
Botswana
1
Bolivia
1
Libya
1
Yemen
1
West and Central Africa
1
Paraguay
1
Solomon Islands
1
Bhutan
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
74
Clinical Guidelines
38
Women & Child Health
12
Public Health
5
Pharmacy & Technologies
4
Key Resources
3
Capacity Building
1
Toolboxes
COVID-19
67
Polio
29
Rapid Response
16
Ebola
13
NTDs
10
TB
9
Pharmacy
9
HIV
8
Cholera
6
Conflict
6
Refugee
5
Zika
4
Planetary Health
3
Natural Hazards
2
Mental Health
2
AMR
2
Specific Hazards
1
Global Health Education
1
Health Financing Toolbox
1
NCDs
1
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an
...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID
...
The current SEARVAP (South-East Asia regional vaccine action plan) describes a set of regional goals and objectives for immunization and control of vaccine-preventable diseases for 2016 – 2020 and highlights priority actions, targets and indicators that address the specific needs and challenges of
...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been
...
This document provides guidance on interventions to prevent vaccine-preventable disease outbreaks in the context of mass population movement resulting from the ongoing crisis in Ukraine.
Available in different languages
It is recommended that egg based quadrivalent vaccines for use in the 2019-2020 northern hemisphere influenza season contain the following:
an A/Brisbane/02/2018 (H1N1)pdm09-like virus;
an A(H3N2) virus to be announced on 21 March 2019*
...
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A countrywide mass vaccination campaign with the
use of an ina
...
The new WHO recommendations for rabies immunization supersede the 2010 WHO position
on pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for rabies. These updated
recommendations are based on new evidence and directed by public health needs that are cost-,
dose- and time-sparing
...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition
...
WHO Secretariat Information paper July 2016
3 February 2021
Vaccine- and vaccination-related crises require a communication response that is different from the communication strategies used to promote the benefits and importance of vaccines in general. This document presents the technical gu
...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19
...
Review
Triccas and Counoupas Pneumonia (2016) 8:18; DOI 10.1186/s41479-016-0020-z
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendation
...
